Fig. 6From: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verificationTopological analysis of the protein–protein interaction network (A) and GO/KEGG enrichment analysis (B, C). GO: genetic selection; KEGG: biological pathways. GO patents were linked with response to stimulus, metabolic process, and biological regulationBack to article page